Frequency and Prognostic Impact of CDKN2A/B Alteration in Oligodendrogliomas: Systematic Review and Meta-analysis
Isocitrate dehydrogenase (IDH)-mutant astrocytomas with homozygous deletion of cyclin-dependent kinase 2A/B (CDKN2A/B-HomoD) are categorized to grade 4 in the new World Health Organization (WHO) classification. However, the clinical implications of CDKN2A/B-HomoD in oligodendrogliomas remain unclear...
Saved in:
Main Authors: | Satoshi NAKASU, Shoichi DEGUCHI, Yoko NAKASU |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japan Neurosurgical Society
2024-12-01
|
Series: | Neurologia Medico-Chirurgica |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/nmc/64/12/64_2024-0105/_pdf/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical characteristics and prognostic analysis of CDKN2A/2B gene in pediatric acute lymphoblastic leukemia: a retrospective case-control study
by: Shi-Mei Huang, et al.
Published: (2025-12-01) -
Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas
by: Xinli Zhang, et al.
Published: (2024-12-01) -
Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma
by: Alexander S. Himstead, et al.
Published: (2025-01-01) -
Prognostic impact of tumor size on cancer-specific survival for postoperative WHO grade II oligodendroglioma: a SEER-based study
by: Qin Lu, et al.
Published: (2025-02-01) -
Homozygous Microdeletion Involving Exon 1 of ERCC8 and NDUFAF2 With Uniparental Isodisomy of Chromosome 5
by: Kaori Yamoto, et al.
Published: (2024-12-01)